Razuprotafib Completed Phase 1 Trials for Healthy Subjects (HS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02858271Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778